​​
Statement from Secretary Seshamani on importance of hepatitis B birth​ dose for all newborns

Dec. 5, 2025

Media Contact:
Amanda Hils, Assistant Director for Media Relations, [email protected]

“This week’s federal Advisory Committee on Immunization Practices’ (ACIP) discussion and vote to change the hepatitis B vaccine recommendations for infants is an alarm bell for all who hold rigorous, evidence-based science as their North Star. 

“The hepatitis B vaccine has been tested extensively for safety and efficacy for decades, and when administered within 24 hours of birth, is highly effective in preventing newborn infection. Delaying the vaccine or not completing the full series has no known safety benefits for children. The ACIP’s action will lead to worse health outcomes for Maryland newborns. 

“Vaccines are one of the most powerful and effective tools to protect against severe illness and keep our communities healthy. The Maryland Department of Health will continue to take the necessary steps to ensure broad vaccine access in Maryland and protect our people.”